[1]
Nalamachu, MD, S., Ruck, ARNP, D., Nalamasu, R., Fasbinder, S. and Bansal, R. 2013. Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain. Journal of Opioid Management. 9, 1 (Jan. 2013), 43–49.